DIA
VKTX icon

Dana Investment Advisors’s Viking Therapeutics VKTX Stock Holding History

Dana Investment Advisors’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.26M Sell
57,854
-1,902
-3% -$61.4K 0.06% 318
2026
Q1 		$1.94M Buy
59,756
+3,763
+7% +$121K 0.06% 316
2025
Q4 		$1.97M Sell
55,993
-9,991
-15% -$354K 0.06% 302
2025
Q3 		$1.73M Buy
65,984
+20,595
+45% +$614K 0.05% 321
2025
Q2 		$1.2M Buy
45,389
+26,237
+137% +$691K 0.04% 363
2025
Q1 		$463K Buy
19,152
+2,401
+14% +$75.9K 0.02% 453
2024
Q4 		$674K Sell
16,751
-3,109
-16% -$177K 0.02% 431
2024
Q3 		$1.26M Buy
19,860
+9,917
+100% +$582K 0.04% 360
2024
Q2 		$527K Buy
9,943
+7,042
+243% +$462K 0.02% 433
2024
Q1 		$238K Buy
+2,901
New +$129K 0.01% 507

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dana Investment Advisors's VKTX Position: Q2 2026 in Review

Dana Investment Advisors reduced its Viking Therapeutics (VKTX) stake by 3.2% in Q2 2026, selling an estimated $61.4K and leaving 57,854 shares worth $2.26M. The position accounts for 0.06% of the portfolio, ranked #318.

Dana Investment Advisors first reported a position in VKTX in Q1 2024 and has held it in 10 quarters since. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Dana Investment Advisors held 57,854 shares of Viking Therapeutics worth $2.26M as of Q2 2026.
  • Dana Investment Advisors sold 1,902 Viking Therapeutics shares in Q2 2026, an estimated $61.4K.
  • Viking Therapeutics made up 0.06% of Dana Investment Advisors's portfolio in Q2 2026, its #318 holding.
  • Dana Investment Advisors first reported a position in Viking Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Dana Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.